CAMBRIDGE, Mass.--(BUSINESS WIRE)--RaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA, today announced the company’s CEO, Ronald Renaud, will present a corporate overview at the 19th Annual BIO CEO & Investor Conference at 9:45 a.m. ET on Tuesday, Feb. 14. The conference will take place at the Waldorf Astoria in New York City.
The presentation will be webcasted and available in the Media Center section of RaNA's website, www.ranarx.com. A replay of the webcast will also be archived for up to 90 days on the company’s website following the conference.
About RaNA Therapeutics
RaNA Therapeutics is a leading biotechnology company committed to the development of next generation RNA-targeted medicines. RaNA’s mission is to improve the lives of people suffering from serious life-altering diseases by creating precision medicines that can change the course of their condition. RaNA’s technology has broad therapeutic potential to treat a wide range of diseases, including rare genetic disorders. For more information about the company and its platforms, please visit www.ranarx.com.